Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mirati Therapeutics, Inc. | 60,000 | reported | 22 Jan 2016 | tx 9+302,000−10,000 |
| HALOZYME THERAPEUTICS, INC. | 45,568 | reported | 22 Feb 2017 | tx 3+452,383 |
| Poseida Therapeutics, Inc. | 0 | reported | 08 Jan 2025 | tx 26+2,283,946−2,654,173 |
| AMYLIN PHARMACEUTICALS INC | 0 | reported | 08 Aug 2012 | tx 105+594,621.4−669,375.6 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Jan 2025 | TENDER | Poseida Therapeutics, Inc. | 636,726 | — | |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 240,721 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 172,600 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 48,115 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 518,500 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 364,060 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 342,000 | 0.00 USD | deriv |
| 02 Jan 2025 | TAX_WITHHOLDING | Poseida Therapeutics, Inc. | 23,313 | 9.60 USD | |
| 10 Dec 2024 | EXERCISE | Poseida Therapeutics, Inc. | 30,000 | 2.78 USD | |
| 10 Dec 2024 | SALE | Poseida Therapeutics, Inc. | 30,000 | 9.46 USD | anomaly |
| 10 Dec 2024 | EXERCISE | Poseida Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 26 Nov 2024 | SALE | Poseida Therapeutics, Inc. | 30,000 | 9.27 USD | anomaly |
| 26 Nov 2024 | EXERCISE | Poseida Therapeutics, Inc. | 30,000 | 2.78 USD | |
| 26 Nov 2024 | EXERCISE | Poseida Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 01 Mar 2024 | TAX_WITHHOLDING | Poseida Therapeutics, Inc. | 34,157 | 4.13 USD | |
| 01 Feb 2024 | TAX_WITHHOLDING | Poseida Therapeutics, Inc. | 47,162 | 3.41 USD | |
| 02 Jan 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 125,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 172,600 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Poseida Therapeutics, Inc. | 269,586 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Poseida Therapeutics, Inc. | 364,060 | 0.00 USD | deriv |
| 01 Feb 2023 | TAX_WITHHOLDING | Poseida Therapeutics, Inc. | 31,819 | 7.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Poseida Therapeutics, Inc. | 357,200 | 0.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Poseida Therapeutics, Inc. | 518,500 | 0.00 USD | deriv |
| 04 Feb 2021 | GRANT_AWARD | Poseida Therapeutics, Inc. | 342,000 | 0.00 USD | deriv |